Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Primo N Lara

Showing results (101-110 of 274) with videos related to

Pageof 28
Sort By:
World Journal of Urology|June 17, 2016
Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer RegistryStanley A Yap, Lindsay M Yuh, Christopher P Evans, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 1, 2018
A contemporary population-based study of testicular sex cord stromal tumours: Presentation, treatment patterns, and predictors of outcomeLindsay M Yuh, Primo N Lara, Rebecca M Wagenaar, et al.
Urology Practice|June 14, 2023
The Promise and Disappointment of Neoadjuvant Chemotherapy and Transurethral Resection for Muscle Invasive Bladder Cancer: Updated Results and Long-Term FollowupStanley A Yap, Neil Pugashetti, Thenappan Chandrasekar, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancerMelinda M Mortenson, Michael G Schlieman, Subbulakshmi Virudachalam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2009
Intermittent erlotinib in combination with pemetrexed: phase I schedules designed to achieve pharmacodynamic separationAngela M Davies, Cheryl Ho, Laurel Beckett, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 11, 2003
Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involvedPeter F Roberts, Michaela Straznicka, Primo N Lara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2010
Racial disparities on the use of invasive and noninvasive staging in patients with non-small cell lung cancerJennifer Marie Suga, Danh V Nguyen, Sandra M Mohammed, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 22, 2014
Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancerDavid T Cooke, David R Gandara, Neal C Goodwin, et al.
Seminars in Oncology|February 26, 2004
Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapyPrimo N Lara, Angela M Davies, Philip C Mack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: a California cancer consortium phase I pharmacokinetic and molecular correlative trialPrimo N Lara, Philip C Mack, Timothy Synold, et al.
Pageof 28

Showing results (101-110 of 274) with videos related to

Sort By:
Pageof 28
World Journal of Urology|June 17, 2016
Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer RegistryStanley A Yap, Lindsay M Yuh, Christopher P Evans, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 1, 2018
A contemporary population-based study of testicular sex cord stromal tumours: Presentation, treatment patterns, and predictors of outcomeLindsay M Yuh, Primo N Lara, Rebecca M Wagenaar, et al.
Urology Practice|June 14, 2023
The Promise and Disappointment of Neoadjuvant Chemotherapy and Transurethral Resection for Muscle Invasive Bladder Cancer: Updated Results and Long-Term FollowupStanley A Yap, Neil Pugashetti, Thenappan Chandrasekar, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancerMelinda M Mortenson, Michael G Schlieman, Subbulakshmi Virudachalam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2009
Intermittent erlotinib in combination with pemetrexed: phase I schedules designed to achieve pharmacodynamic separationAngela M Davies, Cheryl Ho, Laurel Beckett, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 11, 2003
Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involvedPeter F Roberts, Michaela Straznicka, Primo N Lara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2010
Racial disparities on the use of invasive and noninvasive staging in patients with non-small cell lung cancerJennifer Marie Suga, Danh V Nguyen, Sandra M Mohammed, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 22, 2014
Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancerDavid T Cooke, David R Gandara, Neal C Goodwin, et al.
Seminars in Oncology|February 26, 2004
Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapyPrimo N Lara, Angela M Davies, Philip C Mack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: a California cancer consortium phase I pharmacokinetic and molecular correlative trialPrimo N Lara, Philip C Mack, Timothy Synold, et al.
Pageof 28